• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia.

作者信息

Hubert Gervaise, Bittencourt Henrique, Laverdière Caroline, Teira Pierre, Cellot Sonia, Langlois Sylvie, Rouette Alexandre, Sontag Thomas, Sinnett Daniel, Dal-Soglio Dorothée, Turpin Sophie, Tran Thai Hoa

机构信息

Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec.

Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada; Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec.

出版信息

Haematologica. 2023 Jun 1;108(6):1707-1712. doi: 10.3324/haematol.2022.281926.

DOI:10.3324/haematol.2022.281926
PMID:36384252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10230417/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ef/10230417/3127a440e434/1081707.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ef/10230417/5af90d530577/1081707.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ef/10230417/3127a440e434/1081707.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ef/10230417/5af90d530577/1081707.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ef/10230417/3127a440e434/1081707.fig2.jpg

相似文献

1
Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia.达拉非尼与化疗对克隆相关组织细胞增多症和急性淋巴细胞白血病的临床反应
Haematologica. 2023 Jun 1;108(6):1707-1712. doi: 10.3324/haematol.2022.281926.
2
Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell Histiocytosis.达巴非尼治疗 20 例 BRAFV600E 突变朗格汉斯细胞组织细胞增生症患儿的有效性和安全性。
Cancer Res Treat. 2021 Jan;53(1):261-269. doi: 10.4143/crt.2020.769. Epub 2020 Sep 15.
3
[A case of neonatal multi-system Langerhans cell histiocytosis treated by dabrafenib].[1例采用达拉非尼治疗的新生儿多系统朗格汉斯细胞组织细胞增生症]
Zhonghua Er Ke Za Zhi. 2023 Jul 2;61(7):655-658. doi: 10.3760/cma.j.cn112140-20230301-00149.
4
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.维奈托克联合波纳替尼治疗T315I/复合突变的Ph+急性淋巴细胞白血病
Blood Cancer J. 2022 Jan 28;12(1):20. doi: 10.1038/s41408-022-00621-9.
5
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.波纳替尼联合维奈托克治疗复发/难治性费城染色体阳性急性淋巴细胞白血病的有效无化疗方案。
Am J Hematol. 2021 Jul 1;96(7):E229-E232. doi: 10.1002/ajh.26175. Epub 2021 Apr 12.
6
Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.一名复发的费城染色体阳性急性淋巴细胞白血病儿童在造血干细胞移植前对波纳替尼的反应。
Pediatr Int. 2018 Jan;60(1):85-87. doi: 10.1111/ped.13437.
7
Langerhans cell histiocytosis following childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病后朗格汉斯细胞组织细胞增多症
Am J Hematol. 2001 Dec;68(4):284-6. doi: 10.1002/ajh.10004.
8
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study.Hyper-CVAD与波纳替尼联合作为费城染色体阳性急性淋巴细胞白血病患者的一线治疗：一项单中心2期研究的长期随访
Lancet Haematol. 2018 Dec;5(12):e618-e627. doi: 10.1016/S2352-3026(18)30176-5.
9
The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.波纳替尼在费城染色体阳性急性淋巴细胞白血病中的作用。
Expert Rev Anticancer Ther. 2015 Apr;15(4):365-73. doi: 10.1586/14737140.2015.1025256. Epub 2015 Mar 12.
10
Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia.帕纳替尼治疗慢性髓性白血病和费城染色体阳性急性淋巴细胞白血病。
Future Oncol. 2019 Jan;15(3):257-269. doi: 10.2217/fon-2018-0371. Epub 2018 Sep 25.

本文引用的文献

1
Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?病例报告：新生儿多系统朗格汉斯细胞组织细胞增生症中维莫非尼与标准化疗的早期联合应用：能否借此获得更好的治疗结果？
Front Oncol. 2021 Dec 13;11:794498. doi: 10.3389/fonc.2021.794498. eCollection 2021.
2
Histiocytosis.组织细胞增生症。
Lancet. 2021 Jul 10;398(10295):157-170. doi: 10.1016/S0140-6736(21)00311-1. Epub 2021 Apr 23.
3
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.
儿童肿瘤学组 AALL0434：一项测试新诊断 T 细胞急性淋巴细胞白血病中奈拉滨的 III 期随机临床试验。
J Clin Oncol. 2020 Oct 1;38(28):3282-3293. doi: 10.1200/JCO.20.00256. Epub 2020 Aug 19.
4
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review.异基因移植后使用达雷妥尤单抗成功治疗血小板减少症：一例病例报告及文献综述
Blood Adv. 2020 Mar 10;4(5):815-818. doi: 10.1182/bloodadvances.2019001215.
5
Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients.对三例小儿患者中的急性白血病和克隆相关组织细胞肉瘤进行全基因组分析。
Pediatr Blood Cancer. 2020 Feb;67(2):e28074. doi: 10.1002/pbc.28074. Epub 2019 Nov 18.
6
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.维莫非尼治疗儿童难治性多系统朗格汉斯细胞组织细胞增生症：一项国际观察性研究。
J Clin Oncol. 2019 Nov 1;37(31):2857-2865. doi: 10.1200/JCO.19.00456. Epub 2019 Sep 12.
7
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.非朗格汉斯细胞组织细胞增多症成人中髓系肿瘤的高患病率。
Blood. 2017 Aug 24;130(8):1007-1013. doi: 10.1182/blood-2017-01-761718. Epub 2017 Jul 5.
8
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
9
Recurrent BRAF mutations in Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症中的 BRAF 基因突变复发。
Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083. Epub 2010 Jun 2.
10
Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.急性淋巴细胞白血病后组织细胞病变的临床病理特征，并附文献综述。
Pediatr Dev Pathol. 2010 May-Jun;13(3):225-37. doi: 10.2350/09-03-0622-OA.1.